1. Home
  2. VHI vs ORKA Comparison

VHI vs ORKA Comparison

Compare VHI & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VHI
  • ORKA
  • Stock Information
  • Founded
  • VHI 1932
  • ORKA 2004
  • Country
  • VHI United States
  • ORKA United States
  • Employees
  • VHI N/A
  • ORKA N/A
  • Industry
  • VHI Major Chemicals
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VHI Industrials
  • ORKA Health Care
  • Exchange
  • VHI Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • VHI 709.1M
  • ORKA 1.0B
  • IPO Year
  • VHI N/A
  • ORKA N/A
  • Fundamental
  • Price
  • VHI $22.25
  • ORKA $19.97
  • Analyst Decision
  • VHI Sell
  • ORKA Strong Buy
  • Analyst Count
  • VHI 1
  • ORKA 6
  • Target Price
  • VHI $20.00
  • ORKA $43.60
  • AVG Volume (30 Days)
  • VHI 29.1K
  • ORKA 394.7K
  • Earning Date
  • VHI 11-07-2024
  • ORKA 02-15-2025
  • Dividend Yield
  • VHI 1.38%
  • ORKA N/A
  • EPS Growth
  • VHI N/A
  • ORKA N/A
  • EPS
  • VHI 3.08
  • ORKA N/A
  • Revenue
  • VHI $2,076,900,000.00
  • ORKA N/A
  • Revenue This Year
  • VHI $19.58
  • ORKA N/A
  • Revenue Next Year
  • VHI $11.92
  • ORKA N/A
  • P/E Ratio
  • VHI $7.40
  • ORKA N/A
  • Revenue Growth
  • VHI 10.99
  • ORKA N/A
  • 52 Week Low
  • VHI $12.12
  • ORKA $17.64
  • 52 Week High
  • VHI $41.75
  • ORKA $53.88
  • Technical
  • Relative Strength Index (RSI)
  • VHI 37.20
  • ORKA N/A
  • Support Level
  • VHI $21.35
  • ORKA N/A
  • Resistance Level
  • VHI $23.55
  • ORKA N/A
  • Average True Range (ATR)
  • VHI 1.22
  • ORKA 0.00
  • MACD
  • VHI 0.27
  • ORKA 0.00
  • Stochastic Oscillator
  • VHI 30.07
  • ORKA 0.00

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Share on Social Networks: